Your browser doesn't support javascript.
loading
Differentiation of patients with and without prostate cancer using urine 1 H NMR metabolomics.
Hasubek, Anna-Laura; Wang, Xiaoyu; Zhang, Ella; Kobus, Marta; Chen, Jiashang; Vandergrift, Lindsey A; Kurreck, Annika; Ehret, Felix; Dinges, Sarah; Hohm, Annika; Tilgner, Marlon; Buko, Alexander; Habbel, Piet; Nowak, Johannes; Mercaldo, Nathaniel D; Gusev, Andrew; Feldman, Adam S; Cheng, Leo L.
Afiliación
  • Hasubek AL; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Wang X; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Zhang E; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Kobus M; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Chen J; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Vandergrift LA; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Kurreck A; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Ehret F; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Dinges S; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Hohm A; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Tilgner M; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Buko A; Human Metabolome Technologies, Boston, Massachusetts, USA.
  • Habbel P; Charite - Universitatsmedizin Berlin, Berlin, Germany.
  • Nowak J; SRH Poliklinik Gera GmbH, Radiology Gotha, Gotha, Germany.
  • Mercaldo ND; SRH University of Applied Health Sciences, Gera, Germany.
  • Gusev A; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Feldman AS; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Cheng LL; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Magn Reson Chem ; 61(12): 740-747, 2023 12.
Article en En | MEDLINE | ID: mdl-37654196
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans / Male Idioma: En Revista: Magn Reson Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans / Male Idioma: En Revista: Magn Reson Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos